Looking to Overcome Limitations in Gene Therapy Space, PBM Capital Backed Startup Launches with $20 M in Series A
SalioGen Therapeutics, a Burlington-based biotech startup, announced on March 1st that it had closed its $20 million Series A financing round. The funds will support preclinical validation of mammal-derived enzyme …
Read More